A new network of state-regulated compounding pharmacies aims to help compounders that meet a higher bar -- based on accreditation and quality standards -- negotiate with payors and pharmacy benefit managers, which in recent weeks have begun limiting coverage of certain compounded drugs due to the rising costs of the products. The latest move adds to other recent efforts by compounders to curb the coverage restrictions, which industry, payors and PBMs attribute to billing changes and increased utilization. The United...